Concepedia

W P Tong

WP

Statistics

Publications

26

Citations

1.8K

H-Index

19

Active since

1979

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

University of Vermont

W P Tong is an author at Memorial Sloan Kettering Cancer Center specializing in pharmacology, medicine, and chemotherapy.

Publications per year

1979–2002

26

Publications

26

Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.

Jessica Conti, Nancy E. Kemeny, Leonard B. Saltz et al. · Journal of Clinical Oncology · 1996 · 343 citations

Medicine, Oncology, Pharmacology +15

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.

D. Fennelly, Carol Aghajanian, F.L. Shapiro et al. · Journal of Clinical Oncology · 1997 · 249 citations

Medicine, Oncology, Pharmacology +14

Phase I Study of Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic Irinotecan for Unresectable Hepatic Metastases From Colorectal Cancer

Nancy Kemeny, Mithat Gönen, Deidre Sullivan et al. · Journal of Clinical Oncology · 2001 · 184 citations

Pharmacy, Oncology, Pharmacokinetics +17

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.

Andrew D. Seidman, Daniel Hochhauser, M Gollub et al. · Journal of Clinical Oncology · 1996 · 152 citations

Medicine, Oncology, Pharmacology +17

Phase I Clinical and Pharmacology Study of Topotecan Given Daily for 5 Consecutive Days to Patients With Advanced Solid Tumors, With Attempt at Dose Intensification Using Recombinant Granulocyte Colony-Stimulating Factor

Leonard B. Saltz, Matthew N. Sirott, Charles W. Young et al. · JNCI Journal of the National Cancer Institute · 1993 · 135 citations

Medicine, Oncology, Pharmacology +10

1–5 of 26